Compound Detail
CHEMBL2105728
CRENOLANIB 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
Basic Information
| ChEMBL ID | CHEMBL2105728 |
| Name | CRENOLANIB |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | DYNHJHQFHQTFTP-UHFFFAOYSA-N |
69
Targets
118
Activities
2
Assay Types
1
PK Parameters
20
Publications
6
Known Names
6
Indications
2
Mechanisms
Molecular Properties
443.6
MW (Da)
3.92
ALogP
7
HBA
1
HBD
78.4
PSA (Ų)
0.50
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Platelet-derived growth factor receptor inhibitor | INHIBITOR | Platelet-derived growth factor receptor | ✓ | ✓ |
| Tyrosine-protein kinase receptor FLT3 inhibitor | INHIBITOR | Receptor-type tyrosine-protein kinase FLT3 | ✓ | ✓ |
Indications
Gastrointestinal Stromal Tumors Leukemia, Myeloid, Acute Glioblastoma Paraganglioma Diffuse Intrinsic Pontine Glioma Stomach Neoplasms
Activity Summary
Kd 79 meas. best 10.8
IC50 39 meas. best 10.22
Target Activity Profile
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| t1/2 | - | - | - |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine